Researchers in England are kicking off the world's first large human trial of a "universal" influenza shot.
Serum Institute of India has new results from a phase 3 trial of its rotavirus vaccine as it preps to deliver millions of doses.
After a major cancer vaccine misstep, Bavarian Nordic reported positive six-week data from an ongoing phase 2 study on its RSV vaccine candidate.
Inovio and GeneOne have started a clinical study of their MERS vaccine in South Korea, where the virus took 36 lives in a 2015 outbreak.
Johnson & Johnson and a U.S. development agency are zeroing in on pandemic flu in a novel deal focusing on vaccine and flu drug candidates.
Secretive Moderna shared a new peek into its infectious disease vaccines efforts Thursday.
A phase 3 study shows that Seqirus' MF59-adjuvanted quadrivalent flu vaccine provides better protection in those younger than two years old.
PATH, Walter Reed and GSK have partnered to determine whether tweaking the regimen of Mosquirix could lead to better malaria protection.
Themis secured £3 million from Innovate UK for its Chikungunya vaccine project.
An American university and a group of wealthy libertarians, including Peter Thiel, are backing the offshore testing of an experimental herpes vaccine.